The Latin American Examiner
SEE OTHER BRANDS

The top news stories from Latin America

The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

Press releases published on July 9, 2025

Plus de 1,46 millions d’onces d’or ont été estimées par Emperor Metals sur la propriété Duquesne West de Globex

Plus de 1,46 millions d’onces d’or ont été estimées par Emperor Metals sur la propriété Duquesne West de Globex

ROUYN-NORANDA, Québec, 09 juill. 2025 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang …

Game Changer Alert: BAY Miner Unleashes AI-Powered Green Cloud Mining, Making Crypto Wealth Creation Accessible and Sustainable for All

Game Changer Alert: BAY Miner Unleashes AI-Powered Green Cloud Mining, Making Crypto Wealth Creation Accessible and Sustainable for All

LONDON, UK, July 09, 2025 (GLOBE NEWSWIRE) -- BAY Miner, a trailblazer in the cloud mining industry, today announced a significant advancement in its mission to democratize access to digital assets with the comprehensive rollout of its AI-powered green …

EarnMining Launches Innovative Bitcoin Cloud Mining Platform with Free Sign-Up Bonus and Daily Rewards

EarnMining Launches Innovative Bitcoin Cloud Mining Platform with Free Sign-Up Bonus and Daily Rewards

London, UK, July 09, 2025 (GLOBE NEWSWIRE) -- EarnMining has officially unveiled its advanced cloud-based Bitcoin mining platform, designed to revolutionize how individuals access and profit from cryptocurrency. The platform’s primary goal is to break down …

NR7 Miner Launches Industry-First XRP Cloud Mining: AI-Optimized Access Powered by Sustainable Energy

NR7 Miner Launches Industry-First XRP Cloud Mining: AI-Optimized Access Powered by Sustainable Energy

Los Angeles, California, July 09, 2025 (GLOBE NEWSWIRE) -- XRP Mining: NR7 Miner Deploys AI-Optimized Renewable Infrastructure Los Angeles, CA – July 9, 2025 – Sustainable Mining Innovator NR7 Announces Breakthrough Support for XRP Cloud Mining Contracts …

New Cloud Mining App from Ripplecoin Mining Boosts Daily Earnings for BTC, XRP, DOGE Investors via AI-Powered Automation

New Cloud Mining App from Ripplecoin Mining Boosts Daily Earnings for BTC, XRP, DOGE Investors via AI-Powered Automation

San Diego, California, July 09, 2025 (GLOBE NEWSWIRE) -- Founded in 2017, Ripplecoin Mining is a free cloud mining platform headquartered in London, UK. In its 8-year history of operation, it has always been committed to providing safe, convenient and …

Bitget Partners With UNTOLD Festival, Where Web3 Takes The Main Stage

Bitget Partners With UNTOLD Festival, Where Web3 Takes The Main Stage

Bitget headlines the global stage as UNTOLD’s exclusive Web3 partner CLUJ-NAPOCA, Romania, July 09, 2025 (GLOBE NEWSWIRE) -- Bitget, the world’s leading cryptocurrency exchange and Web3 company, has collaborated with UNTOLD - one of the top three music …

XRP Mining Introduces Hassle-Free Mobile Cloud Mining App For Earning Crypto Daily

XRP Mining Introduces Hassle-Free Mobile Cloud Mining App For Earning Crypto Daily

Chicago, Illinois, July 09, 2025 (GLOBE NEWSWIRE) -- Let’s be honest — traditional crypto mining is a serious commitment:You’ll need high-end hardware that can cost thousands.Electricity bills can skyrocket.The noise and heat from mining rigs? A nightmare. …

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory …

Surge Copper Announces Upsize of Private Placement to $10.4 Million

Surge Copper Announces Upsize of Private Placement to $10.4 Million

Not for distribution to U.S. newswire services or dissemination in the United States Vancouver, British Columbia, July 09, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to …

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis Carlsbad, CA, July 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“ …

Bitget Integrates xStocks to Bring Wall Street to Web3 with Tokenized Stocks on Onchain

Bitget Integrates xStocks to Bring Wall Street to Web3 with Tokenized Stocks on Onchain

VICTORIA, Seychelles, July 09, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has introduced support for tokenized stocks via its Onchain platform, following an integration with xStocks that bridges traditional …

New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials

New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials

Article Indicates that Inhibition of PP2A Enhances Immunotherapy Response with LIXTE’s Proprietary Compound LB100 PASADENA, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a …

Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates

Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates

Custom-built model will be trained using Revolution Medicines’ proprietary data to discover novel drug candidates Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for services …

Amneal to Report Second Quarter 2025 Results on August 5, 2025

Amneal to Report Second Quarter 2025 Results on August 5, 2025

BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial results on …

Benitec Biopharma Provides Operational Updates

Benitec Biopharma Provides Operational Updates

-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)- -Independent Data Safety Monitoring Board Review Has Been Completed for All Six Subjects …

DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors

DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage clinical biopharmaceutical company developing covalently bonded dimer therapeutics, today announced the appointment of Sergio Traversa, PharmD, as an Independent Director to its …

Sonoro Gold PROVIDES AN UPDATE ON THE ENVIRONMENTAL PERMIT (mia)   FOR THE CERRO CALICHE GOLD PROJECT

Sonoro Gold PROVIDES AN UPDATE ON THE ENVIRONMENTAL PERMIT (mia) FOR THE CERRO CALICHE GOLD PROJECT

VANCOUVER, Canada, July 09, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to provide an update on the status of the Environmental Impact Statement, or Manifestacion de Impacto …

Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity

-- Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reductions in bivamelagon trial were consistent with BMI …

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential …

Amerigo Reports Q2-2025 Operational Results

Amerigo Reports Q2-2025 Operational Results

Q2-2025 copper production of 15.5 million pounds 2025 production and cash cost1 guidance remain in place $7.6 million returned through Share Buybacks and Dividends in Q2-2025 VANCOUVER, British Columbia, July 09, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service